VCIM
Velan Capital Investment Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,528,601
| Closed | -$10.1M | – | 18 |
|
|
2024
Q1 | $10.1M | Sell |
1,528,601
-607,499
| -28% | -$4.01M | 4.58% | 5 |
|
|
2023
Q4 | $9.66M | Buy |
2,136,100
+400,000
| +23% | +$1.81M | 5.64% | 3 |
|
|
2023
Q3 | $6.22M | Sell |
1,736,100
-989,951
| -36% | -$3.54M | 5.01% | 5 |
|
|
2023
Q2 | $10.1M | Sell |
2,726,051
-1,273,949
| -32% | -$4.7M | 9.34% | 2 |
|
|
2023
Q1 | $13.2M | Hold |
4,000,000
| – | – | 11.29% | 2 |
|
|
2022
Q4 | $15.5M | Sell |
4,000,000
-1,269,155
| -24% | -$4.92M | 13.71% | 1 |
|
|
2022
Q3 | $12.8M | Sell |
5,269,155
-804,443
| -13% | -$1.95M | 12.7% | 3 |
|
|
2022
Q2 | $12M | Buy |
6,073,598
+250,800
| +4% | +$497K | 12.2% | 3 |
|
|
2022
Q1 | $10.7M | Buy |
5,822,798
+425,000
| +8% | +$778K | 9.89% | 3 |
|
|
2021
Q4 | $7.61M | Buy |
+5,397,798
| New | +$7.61M | 5.91% | 5 |
|